SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurobiological Tech (NTII)
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
1494 40 0 NTII
Emcee:  Miles Rhyne Hoffman, CFA Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
444 is there a conference call this time around ?? what am I missing here, Would bApache Indian-2/12/1999
443 Down to the wire, you have to be one cool cucumber to take this. Lovin it. I wMike McFarland-2/11/1999
442 Neurobiological Technologies, Inc. Announces Second Quarter Results RICHMOND, CBRAVEHEART-2/11/1999
441 Peter, There are three primary reasons why this trial has taken so long to accrDr. John M. de Castro-2/7/1999
440 UNMET NEEDS... "For every ten patients diagnosed with MS 100 patients areBRAVEHEART-2/5/1999
439 Hi Peter, I wish I knew more on the MERZ NTI revenue sharing concept myself. BRAVEHEART-2/4/1999
438 John, Any idea why this trial has taken so long to accrue 100 patients? I thinBiomaven-2/4/1999
437 Memantine for Alzheimers Clinical Trial Protocol alz.org Looks like Merz is gDr. John M. de Castro-2/4/1999
436 Mementine for Aids Dementia Complex Trial Protocol 130.14.32.43 This is a nicDr. John M. de Castro-2/4/1999
435 Manage risk with patience...yes I will go along with that. Nice post.Mike McFarland-1/29/1999
434 Hi Mike, First off I don't think investors will have to wait till we know BRAVEHEART-1/29/1999
433 Well ure looking beyond our primary problem, which is $$$, dinero.. and this alApache Indian-1/29/1999
432 just some chit chat to pass the time... Either memantine does well or it doesMike McFarland-1/29/1999
431 the trickle gets thinner and thinner, if Frieman has done anything for this coApache Indian-1/29/1999
430 Just beating the already quite dead horse... 100k for Xerecept trivial, to inMike McFarland-1/28/1999
429 thats rich huh? coming from the NIH ? Apache Indian-1/28/1999
428 Neurobiological Technologies, Inc. Awarded $100,000 SBIR Grant to Continue PhasApache Indian-1/28/1999
427 Hi Mike, Funny. I know broker recommendations influence people to buy essentiBRAVEHEART-1/27/1999
426 Mike likes to rant too! Maybe I am deluded too and our due diligence is incompMike McFarland-1/27/1999
425 Hi Gang, Out of shere exasperation I strike out. Ya know. It never ceases toBRAVEHEART-1/27/1999
424 Hi Apache Indian, The goals for fiscal 1999 ( started Sept 1998 )are/were as fBRAVEHEART-1/12/1999
423 Aren't they due to report PhaseIIB results on diabetic * sometime soon ?? Apache Indian-1/12/1999
422 Whoa nellie! <i>In fact I have approximately 150 biotechs indexed</i&Mike McFarland-1/11/1999
421 OK IT'S MORE THAN A FEELING Hi Mike, Let's say it's more than aBRAVEHEART-1/11/1999
420 Gee, I don't know if there has been enough volume for a person to get a feMike McFarland-1/11/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News